Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature
Our understanding of the biology, genetics, and natural history of neuroendocrine tumors (NETs) of the gastrointestinal tract and pancreas has improved considerably in the last several decades and the spectrum of available therapeutic options is rapidly expanding. The management of patients with met...
Main Authors: | Vladimir Neychev, Electron Kebebew |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | International Journal of Surgical Oncology |
Online Access: | http://dx.doi.org/10.1155/2017/6424812 |
Similar Items
-
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
by: Mauro Cives, et al.
Published: (2020-11-01) -
Advances in the treatment of gastroenteropancreatic neuroendocrine tumors
by: Pamela L Kunz, et al.
Published: (2010-06-01) -
Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy
by: Judy S. Crabtree
Published: (2017-12-01) -
Medical Treatment of Gastroenteropancreatic Neuroendocrine Tumors
by: Thomas Gress, et al.
Published: (2012-02-01) -
Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
by: Beata Kos-Kudła, et al.
Published: (2017-06-01)